Source link : https://www.newshealth.biz/health-news/ema-recommends-vilobelimabfor-ards-induced-by-sars-cov-2/
Following a consultation with its emergency task force, the European Medicines Agency (EMA) has backed a drug for adult patients with acute respiratory distress syndrome (ARDS) induced by the SARS‑CoV-2 virus. As a result, the EMA’s Committee for Medicinal Products for Human Use recommended granting a marketing authorization “under exceptional circumstances” for vilobelimab (Gohibic). Vilobelimab […]
Author : News Health
Publish date : 2024-11-15 16:44:05
Copyright for syndicated content belongs to the linked Source.